Increased Antibiotic Resistance in Respiratory Tract Pathogens: PROTEKT US—An Update
Open Access
- 1 September 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (Supplement) , S142-S150
- https://doi.org/10.1086/421352
Abstract
Three major North American surveillance programs have tracked antimicrobial resistance patterns among isolates of Streptococcus pneumoniae and other common respiratory tract pathogens. The Canadian Bacterial Surveillance Network shows the progressive increase in resistance among pneumococcal S. pneumoniae to penicillin, trimethoprim-sulfamethoxazole, macrolides, and fluoroquinolones. The data from the Tracking Resistance in the United States Today study also show a steady rise in pneumococcal resistance among common antibiotics as well as an increase in multidrug-resistant S. pneumoniae. The US component of the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study has detected increasing resistance to many antimicrobial agents among common respiratory isolates, with marked geographic variations in resistance patterns. The patterns of resistance detected by these major surveillance programs are a warning signal regarding the continued emergence of resistance among community-acquired respiratory tract pathogens.Keywords
This publication has 14 references indexed in Scilit:
- Acute Community-Acquired Bacterial Sinusitis: Continuing Challenges and Current ManagementClinical Infectious Diseases, 2004
- Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000–01Journal of Infection, 2004
- The need for antimicrobial resistance surveillanceJournal of Antimicrobial Chemotherapy, 2002
- Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000Clinical Infectious Diseases, 2002
- Optimizing Economic Outcomes in Acute Exacerbations of Chronic BronchitisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- The Emerging Role of Atypical Pathogens in Community-Acquired PneumoniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998Journal of Antimicrobial Chemotherapy, 1999
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997